Edition:
India

People: ANI Pharmaceuticals Inc (ANIP.OQ)

ANIP.OQ on NASDAQ Stock Exchange Global Market

77.05USD
21 Jun 2019
Change (% chg)

-- (--)
Prev Close
$77.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
38,839
52-wk High
$78.35
52-wk Low
$39.83

Penn, Thomas 

Mr. Thomas A. Penn is Independent Director of the Company. Mr. Penn is employed by MVP Management, of which he serves as Vice President. MVP Management conducts business as MVP Capital Partners. MVP Management is the investment management company for MVP II, of which Mr. Penn is a Partner. Mr. Penn has also served as a managing director at and owner of Penn Venture I LLC since 2007. Penn Venture I LLC owns fifty percent of Penn Venture Associates, LLC. Penn Venture Associates, LLC is the general partner of Penn Venture Partners, L.P., an investment fund focused on investments in central Pennsylvania. Previously, Mr. Penn served as chief executive officer of Tektagen, Inc. and a partner at Boston Millennia Partners. He also serves or has served as a director of several privately-held service, manufacturing, technology, life sciences and healthcare companies. These companies include Benten BioServices, Inc., Deltagen, Inc., NanoHorizons Inc., GCA Services, Inc., and Andrews International, Inc. Mr. Penn is a graduate of the Massachusetts Institute of Technology, the Stanford University Graduate School of Business, and the University of Pennsylvania Law School.

Basic Compensation

Total Annual Compensation, USD 73,220
Restricted Stock Award, USD 79,032
Long-Term Incentive Plans, USD --
All Other, USD 53,012
Fiscal Year Total, USD 205,264

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Brown

273,573

Arthur Przybyl

4,197,930

Stephen Carey

1,438,750

Robert Schrepfer

1,444,160

James Marken

1,009,590

Thomas Haughey

252,569
As Of  31 Dec 2018